The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Irreversible Electroporation Ablators Market Research Report 2024

Global Irreversible Electroporation Ablators Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1419370

No of Pages : 73

Synopsis
Irreversible electroporation is a soft tissue ablation technique using ultra short but strong electrical fields to create permanent and hence lethal Nano pores in the cell membrane, to disrupt the cellular homeostasis. The resulting cell death results from apoptosis and not necrosis as in all other thermal or radiation based ablation techniques. The main use of IRE lies in tumor ablation in regions where precision and conservation of the extracellular matrix, blood flow and nerves are of importance. The technique is in an experimental stage and has not been approved for use outside of clinical trials. IRE is used in the NanoKnife System.
The global Irreversible Electroporation Ablators market was valued at US$ 26 million in 2023 and is anticipated to reach US$ 48 million by 2030, witnessing a CAGR of 9.1% during the forecast period 2024-2030.
The world's leading manufacturers of irreversible electroporation ablators are AngioDynamics and Pulse Biosciences. North America is the largest consumption place, with a consumption market share nearly 56%. Following North America, Europe is the second largest consumption place with the consumption market share of 25%.
This report aims to provide a comprehensive presentation of the global market for Irreversible Electroporation Ablators, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Irreversible Electroporation Ablators.
Report Scope
The Irreversible Electroporation Ablators market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Irreversible Electroporation Ablators market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Irreversible Electroporation Ablators manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AngioDynamics
Pulse Biosciences
Segment by Type
Generator
Part
Service
Segment by Application
Liver
Pancreas
Prostate
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Irreversible Electroporation Ablators manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Irreversible Electroporation Ablators in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Irreversible Electroporation Ablators Market Overview
1.1 Product Overview and Scope of Irreversible Electroporation Ablators
1.2 Irreversible Electroporation Ablators Segment by Type
1.2.1 Global Irreversible Electroporation Ablators Market Value Comparison by Type (2024-2030)
1.2.2 Generator
1.2.3 Part
1.2.4 Service
1.3 Irreversible Electroporation Ablators Segment by Application
1.3.1 Global Irreversible Electroporation Ablators Market Value by Application: (2024-2030)
1.3.2 Liver
1.3.3 Pancreas
1.3.4 Prostate
1.3.5 Others
1.4 Global Irreversible Electroporation Ablators Market Size Estimates and Forecasts
1.4.1 Global Irreversible Electroporation Ablators Revenue 2019-2030
1.4.2 Global Irreversible Electroporation Ablators Sales 2019-2030
1.4.3 Global Irreversible Electroporation Ablators Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Irreversible Electroporation Ablators Market Competition by Manufacturers
2.1 Global Irreversible Electroporation Ablators Sales Market Share by Manufacturers (2019-2024)
2.2 Global Irreversible Electroporation Ablators Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Irreversible Electroporation Ablators Average Price by Manufacturers (2019-2024)
2.4 Global Irreversible Electroporation Ablators Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Irreversible Electroporation Ablators, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Irreversible Electroporation Ablators, Product Type & Application
2.7 Irreversible Electroporation Ablators Market Competitive Situation and Trends
2.7.1 Irreversible Electroporation Ablators Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Irreversible Electroporation Ablators Players Market Share by Revenue
2.7.3 Global Irreversible Electroporation Ablators Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Irreversible Electroporation Ablators Retrospective Market Scenario by Region
3.1 Global Irreversible Electroporation Ablators Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Irreversible Electroporation Ablators Global Irreversible Electroporation Ablators Sales by Region: 2019-2030
3.2.1 Global Irreversible Electroporation Ablators Sales by Region: 2019-2024
3.2.2 Global Irreversible Electroporation Ablators Sales by Region: 2025-2030
3.3 Global Irreversible Electroporation Ablators Global Irreversible Electroporation Ablators Revenue by Region: 2019-2030
3.3.1 Global Irreversible Electroporation Ablators Revenue by Region: 2019-2024
3.3.2 Global Irreversible Electroporation Ablators Revenue by Region: 2025-2030
3.4 North America Irreversible Electroporation Ablators Market Facts & Figures by Country
3.4.1 North America Irreversible Electroporation Ablators Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Irreversible Electroporation Ablators Sales by Country (2019-2030)
3.4.3 North America Irreversible Electroporation Ablators Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Irreversible Electroporation Ablators Market Facts & Figures by Country
3.5.1 Europe Irreversible Electroporation Ablators Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Irreversible Electroporation Ablators Sales by Country (2019-2030)
3.5.3 Europe Irreversible Electroporation Ablators Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Irreversible Electroporation Ablators Market Facts & Figures by Country
3.6.1 Asia Pacific Irreversible Electroporation Ablators Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Irreversible Electroporation Ablators Sales by Country (2019-2030)
3.6.3 Asia Pacific Irreversible Electroporation Ablators Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Irreversible Electroporation Ablators Market Facts & Figures by Country
3.7.1 Latin America Irreversible Electroporation Ablators Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Irreversible Electroporation Ablators Sales by Country (2019-2030)
3.7.3 Latin America Irreversible Electroporation Ablators Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Irreversible Electroporation Ablators Market Facts & Figures by Country
3.8.1 Middle East and Africa Irreversible Electroporation Ablators Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Irreversible Electroporation Ablators Sales by Country (2019-2030)
3.8.3 Middle East and Africa Irreversible Electroporation Ablators Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Irreversible Electroporation Ablators Sales by Type (2019-2030)
4.1.1 Global Irreversible Electroporation Ablators Sales by Type (2019-2024)
4.1.2 Global Irreversible Electroporation Ablators Sales by Type (2025-2030)
4.1.3 Global Irreversible Electroporation Ablators Sales Market Share by Type (2019-2030)
4.2 Global Irreversible Electroporation Ablators Revenue by Type (2019-2030)
4.2.1 Global Irreversible Electroporation Ablators Revenue by Type (2019-2024)
4.2.2 Global Irreversible Electroporation Ablators Revenue by Type (2025-2030)
4.2.3 Global Irreversible Electroporation Ablators Revenue Market Share by Type (2019-2030)
4.3 Global Irreversible Electroporation Ablators Price by Type (2019-2030)
5 Segment by Application
5.1 Global Irreversible Electroporation Ablators Sales by Application (2019-2030)
5.1.1 Global Irreversible Electroporation Ablators Sales by Application (2019-2024)
5.1.2 Global Irreversible Electroporation Ablators Sales by Application (2025-2030)
5.1.3 Global Irreversible Electroporation Ablators Sales Market Share by Application (2019-2030)
5.2 Global Irreversible Electroporation Ablators Revenue by Application (2019-2030)
5.2.1 Global Irreversible Electroporation Ablators Revenue by Application (2019-2024)
5.2.2 Global Irreversible Electroporation Ablators Revenue by Application (2025-2030)
5.2.3 Global Irreversible Electroporation Ablators Revenue Market Share by Application (2019-2030)
5.3 Global Irreversible Electroporation Ablators Price by Application (2019-2030)
6 Key Companies Profiled
6.1 AngioDynamics
6.1.1 AngioDynamics Corporation Information
6.1.2 AngioDynamics Description and Business Overview
6.1.3 AngioDynamics Irreversible Electroporation Ablators Sales, Revenue and Gross Margin (2019-2024)
6.1.4 AngioDynamics Irreversible Electroporation Ablators Product Portfolio
6.1.5 AngioDynamics Recent Developments/Updates
6.2 Pulse Biosciences
6.2.1 Pulse Biosciences Corporation Information
6.2.2 Pulse Biosciences Description and Business Overview
6.2.3 Pulse Biosciences Irreversible Electroporation Ablators Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Pulse Biosciences Irreversible Electroporation Ablators Product Portfolio
6.2.5 Pulse Biosciences Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Irreversible Electroporation Ablators Industry Chain Analysis
7.2 Irreversible Electroporation Ablators Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Irreversible Electroporation Ablators Production Mode & Process
7.4 Irreversible Electroporation Ablators Sales and Marketing
7.4.1 Irreversible Electroporation Ablators Sales Channels
7.4.2 Irreversible Electroporation Ablators Distributors
7.5 Irreversible Electroporation Ablators Customers
8 Irreversible Electroporation Ablators Market Dynamics
8.1 Irreversible Electroporation Ablators Industry Trends
8.2 Irreversible Electroporation Ablators Market Drivers
8.3 Irreversible Electroporation Ablators Market Challenges
8.4 Irreversible Electroporation Ablators Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’